DGS Capital Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.33M Buy
13,631
+3,976
+41% +$926K 0.55% 28
2025
Q4
$2M Buy
9,655
+3,467
+56% +$686K 0.34% 50
2025
Q3
$1.15M Buy
6,188
+1,775
+40% +$304K 0.21% 92
2025
Q2
$674K Buy
4,413
+1,471
+50% +$226K 0.14% 144
2025
Q1
$488K Buy
2,942
+341
+13% +$53.4K 0.13% 163
2024
Q4
$376K Sell
2,601
-2,803
-52% -$434K 0.09% 188
2024
Q3
$876K Buy
5,404
+804
+17% +$128K 0.24% 87
2024
Q2
$672K Sell
4,600
-1,110
-19% -$165K 0.19% 103
2024
Q1
$903K Buy
5,710
+1,635
+40% +$260K 0.26% 69
2023
Q4
$639K Sell
4,075
-733
-15% -$112K 0.25% 79
2023
Q3
$749K Buy
4,808
+412
+9% +$68K 0.37% 59
2023
Q2
$728K Sell
4,396
-153
-3% -$24.7K 0.36% 60
2023
Q1
$705K Sell
4,549
-939
-17% -$152K 0.39% 51
2022
Q4
$969K Buy
5,488
+564
+11% +$97.4K 0.63% 27
2022
Q3
$804K Sell
4,924
-572
-10% -$96.8K 0.54% 27
2022
Q2
$976K Buy
5,496
+1,003
+22% +$179K 0.79% 22
2022
Q1
$796K Buy
4,493
+195
+5% +$33.2K 0.49% 32
2021
Q4
$735K Buy
+4,298
New +$704K 0.46% 33

Other funds holding JNJ

DGS Capital Management's JNJ Position: Q1 2026 in Review

DGS Capital Management increased its Johnson & Johnson (JNJ) stake by 41% in Q1 2026, buying an estimated $926K and bringing the position to 13,631 shares worth $3.33M. The position accounts for 0.55% of the portfolio, ranked #28.

DGS Capital Management first reported a position in JNJ in Q4 2021 and has held it in 18 quarters since. 4,644 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • DGS Capital Management held 13,631 shares of Johnson & Johnson worth $3.33M as of Q1 2026.
  • DGS Capital Management bought 3,976 Johnson & Johnson shares in Q1 2026, an estimated $926K.
  • Johnson & Johnson made up 0.55% of DGS Capital Management's portfolio in Q1 2026, its #28 holding.
  • DGS Capital Management first reported a position in Johnson & Johnson in Q4 2021 and has held it in 18 quarters since.
  • 4,644 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on DGS Capital Management's 13F filing for Q1 2026, filed 28 Apr 2026.